This drug is a small molecule inhibitor of KAT6, a histone acetyltransferase (“HAT”) that is dysregulated in several cancers, including breast, lung, and ovarian cancers. The drug aims to inhibit KAT6, blocking ERα at the transcriptional level, which could be beneficial in the treatment of ER+/HER2- breast cancer.
×
Insilico Medicine � KAT6 Inhibitor (Breast Cancer treatment)
© 2021 - Lifespan Extension Advocacy Foundation - LIFESPAN2023
The opinions expressed in interviews or commentary in articles appearing on this site are those of the subject or subjects and do not necessarily reflect the views of LEAF/Lifespan.io, its directors, officers or employees.
Powered by MMD